A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity

NCT06862908 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Heart Failure With Preserved Ejection Fraction (HFPEF)
Heart Failure With Mildly Reduced Ejection Fraction

Interventions

OTHER: placebo
DRUG: IBI362

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.